jeffrey a. meyerhardt, md, discusses how consensus molecular subtypes help with crc treatment

Published 7 years ago • 117 plays • Length 1:35

Download video MP4
Download video MP3

Similar videos

1:31

jeffrey a. meyerhardt, md, explains which molecular tests help determine treatment approach
1:41

jeffrey a. meyerhardt, md, explains matching mutations and markers to therapies in crc patients
1:01

jeffrey a. meyerhardt, md, discusses immunotherapy in msi-stable crc patients
1:22

jeffrey a. meyerhardt, md, talks about the dfci wellness study
2:14

jeffrey a. meyerhardt, md, on managing 2nd and 3rd line mcrc patients
20:35

01 multistep tumor formation
20:03

brain metastases
58:04

molecular assays for colorectal cancer care - william grady, md
2:56

jeffrey a. meyerhardt, md, talks about the dfci wellness study
1:43

jeffrey a. meyerhardt, md, discusses outcomes of the phase 2 study in braf mutated crc patients
1:20

jeffrey a. meyerhardt, md, considers the beacon study in braf mutated metastatic colorectal cancer
5:55

colorectal cancer – an introduction, with jeffrey a. meyerhardt, md, mph
1:53

jeffrey meyerhardt, md, discusses braf mutation metastatic crc and vemurafenib
0:58

jeffrey a. meyerhardt, md explains how os from primary site of tumor may impact treatment
0:53

jeffrey a. meyerhardt, md discusses the phase 3 calgb/swog 80405 study
1:01

jeffrey a. meyerhardt, md on pd-1 or pd-l1 treatment strategies for msi-stable mcrc patients
1:01

jeffrey a. meyerhardt, md, shares thoughts on checkpoint inhibitors in adjuvant crc
23:32

update 3: molecular subtyping in colorectal cancer
0:48

jeffrey meyerhardt, md, mph, discusses the length of adjuvant therapy for colorectal cancer patients
1:50

jeffrey a. meyerhardt, md, on integrating immunotherapy into treatment regimens for gi cancer
1:02

jeffrey a. meyerhardt, md, on whether regorafenib is becoming more tolerable for mcrc patients
1:05

jeffrey a. meyerhardt, md explains results from the phase 3 calgb/swog 80405 study

Clip.africa.com - Privacy-policy